期刊文献+

盐酸千金藤碱逆转肝癌多药耐药性与P-gpATP酶活性的关系研究 被引量:11

Effect of cepharanthine hydrochloride on overcoming multidrug resistance and P-gp ATPase activity in mice model of hepatocellular carcinoma
下载PDF
导出
摘要 目的观察盐酸千金藤碱(cepharanthine hydrochlo-ride,CH)联合FAP对肝癌多药耐药性的逆转作用及其机制。方法 MTT法检测CH和维拉帕米对耐药细胞的无毒剂量;MTT法检测H22/FAP肝癌细胞对多柔比星、顺铂、5-氟尿嘧啶的耐药倍数;生命延长率评价CH联合FAP的药效;定磷法检测P-gp ATP酶活性。结果细胞毒性检测结果提示,CH和VER剂量分别为1.0、0.15 g.L-1时,对H22/FAP细胞的抑制率<10%;MTT检测显示,H22/FAP瘤细胞对多柔比星、顺铂、5-氟尿嘧啶的耐药倍数分别为27.75、10.20、11.20;生命延长率结果显示CH 10、5 mg.kg-1联合FAP组能有效延长小鼠生存时间;动力学分析提示CH能够提高ATP酶活性,Vmax值约为184 nmol.min-1.mg-1,与阳性对照药维拉帕米相近。结论 CH联合FAP能够逆转肝癌多药耐药性,其机制之一可能为CH能够提高P-gpATP酶活性,抑制P-gp外排功能。 Aim To study the effect of cepharanthine hydrochloride on overcoming multidrug resistance in mice model of hepatocellular carcinoma.Methods Cell toxicity test and drug sensitivity test were assayed by MTT [3-(4,-5-dimethylthiazol)-2,-5-diphenylte-2H-tetrazo lium bromide].The survival time of BALB/c mice was observed by calculating life prolongation rate.The ATPase activity was observed via ATP hydrolisis.Results Cell toxicity test showed the small toxicity of CH and VER on BALB/c mice is 1.0 g·L-1 and 0.15 g·L-1 respectively;Drug sensitivity test with MTT assay showed that CH significantly enhanced cytotoxicity of adriamycin(ADR),cis-dichlorodiamineplatinumn(CDDP),and 5-flurouracil(5-FU) in resistance cells with resistance index(RI) of H22/FAP tumor cells 27.75,10.20,11.20 respectively.CH 10 mg·kg-1,CH 5 mg·kg-1 in combination with FAP prolonged the life of BALB/c mice with the life prolongation rate about 41.0 % and 48.8%(P0.05 vs FAP group).The data showed CH combined with FAP agents prolonged the life of mice significantly.ATP-hydrolisis showed that CH increased ATPase activity with a Vmax of approximately 184 nmol·(min·mg)-1.Conclusion CH combined with FAP agents prolongs the life of mice significantly.One of the mechanisms may be CH in combination with FAP can upregulate the P-gp ATPase activity.
出处 《中国药理学通报》 CAS CSCD 北大核心 2011年第7期1002-1006,共5页 Chinese Pharmacological Bulletin
基金 河南省基础与前沿技术研究计划项目(No082300453204)
关键词 盐酸千金藤碱 肝癌 多药耐药 P-糖蛋白 ATP酶活性 H22细胞 H22/FAP细胞 cepharanthine hydrochloride hepatocellular carcinoma multidruge resistance P-glycoprotein ATPase activity H22 cell H22/FAP cell
  • 相关文献

参考文献6

二级参考文献76

  • 1谭耀红,杨纯正,齐静,王金宏,王彩云,彭辉.3-取代芳基氧化吲哚(PHII-7)对肿瘤细胞周期的影响[J].药学学报,2003,38(11):805-808. 被引量:3
  • 2姬汴生,何玲,刘国卿.氨氯地平衍生物CJX1对K562/DOX细胞阿霉素耐药的逆转作用[J].中国药科大学学报,2005,36(2):159-163. 被引量:8
  • 3戴春岭,符立梧.肿瘤多药耐药逆转剂的研究进展[J].中国药理学通报,2005,21(5):513-518. 被引量:39
  • 4[1]Parkin DM,Bray F,Ferlay J,Pisani P.Global cancer statistics,2002.CA Cancer } Clin 2005; 55:74-108
  • 5[2]Eggel H.Ueber das primare Carcinom der Leber.Beitr Pathol Anat 1910; 30:506-604
  • 6[3]McGlynn KA,London WT.Epidemiology and natural history of hepatocellular carcinoma.Best Pract Res Clin Gastroenterol 2005; 19:3-23
  • 7[4]Chu CM.Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.J Gastroenterol Hepatol 2000; 15 Suppl:E25-E30
  • 8[5]Yu MW,Yeh SH,Chen PJ,Liaw YF,Lin CL,Liu CJ,Shih WL,Kao JH,Chen IDS,Chen CJ.Hepatitis B virus genotype and DNA level and hepatocellular carcinoma:a prospective study in men.J Natl Cancer Inst 2005; 97:265-272
  • 9[6]Liu CJ,Chen BF,Chen PJ,Lai MY,Huang WL,Kao JH,Chen DS.Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers.J Infect Dis 2006; 193:1258-1265
  • 10[7]Marchio A,Pineau P,Meddeb M,Terris B,Tiollais P,Bernheim A,Dejean A.Distinct chromosomal abnormality pattern in primary liver cancer of non-B,non-C patients.Oncogene 2000; 19:3733-3738

共引文献82

同被引文献177

引证文献11

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部